Increased CAMK2 mRNA was associated with significantly worse overall and distant metastasis free survival in the breast cancer patients examined (Fig. 1), indicating that high CAMK2 mRNA is a potentially novel biomarker for breast patient outcome. The gene discussed is CAMK2B; the disease is breast carcinoma.